GEORGE DASTON, The Procter and Gamble Company, Cincinnati, OH. Dr. Daston is a toxicologist at Miami Valley Laboratories of the Procter and Gamble Company. He earned his Ph.D. in teratology from the University of Miami. His research interests include in vitro methodologies, teratogenic mechanisms, and risk assessment. Dr. Daston is a former member of the National Research Council Board on Environmental Studies and Toxicology.
MARK FISHMAN, Massachusetts General Hospital and Harvard Medical School, Boston, MA. Dr. Fishman is chief of cardiology, director of the Cardiovascular Research Center, and chief of the Developmental Biology Laboratory at the Massachusetts General Hospital. He also is a professor of medicine at Harvard Medical School. He earned his M.D. from Harvard Medical School. Dr. Fishman’s research interests are in the development of the heart and other organ systems. He has helped pioneer the use of the zebrafish in large-scale genetic screens and has been instrumental in the discovery of many new genes critical to development of the early embryo.
JOSEPH HOLSON, WIL Research Laboratories, Inc., Ashland, OH. Dr. Holson is president and director of WIL Research Laboratories, Inc. He earned his Ph.D. in physiology from University of Cincinnati College of Medicine. Dr. Holson’s scientific activities are primarily in product development and risk assessment where he specializes in developmental and reproductive toxicology.
HERMAN B.W.M. KOËTER, Organisation for Economic Cooperation and Development (OECD), Paris, France. Dr. Koëter is principal administrator of the OECD Environmental Health and Safety Division. He is responsible for and directs the OECD Test Guidelines Programme, the OECD Programme on Harmonization of Classification and Labeling, the OECD Special Activity on Endocrine Disrupters, and the OECD Special Activity on Animal Welfare Policies. He is also senior adviser for OECD on human health risk characterization and assessment issues. Dr. Koëter earned his masters degree in experimental pathology and his doctoral degree in biological toxicology from Utrecht State University, Utrecht, The Netherlands.
ANTHONY MAHOWALD, University of Chicago, Chicago, IL. Dr. Mahowald is Louis Block professor and chair of the Department of Molecular Genetics and Cell Biology and the Committee on Developmental Biology at the University of Chicago. He received his Ph.D. in biology from Johns Hopkins University. His research interests include the developmental genetics of oogenesis and germ-cell sex determination in Drosophila. Dr. Mahowald is a fellow of the American Academy of Arts and Sciences and a member of the National Academy of Sciences.